Glioma Genetic Diagnosis Software, a clinical decision support tool for non-invasive detection of isocitrate dehydrogenase (IDH) and telomerase reverse transcriptase promoter (TERTp) mutations in gliomas using proton magnetic resonance spectroscopy (1H-MRS) and liquid chromatography-mass spectrometry (LC-MS/MS), was developed in this study. The machine-learning models were trained with the data of 237 gliomas. IDH mutation was identified with 87.04% and of 92.70% accuracies, and TERTp mutation in IDH wildtype gliomas was identified with 87.53% and 85.96% accuracies, using 1H-MRS and MS, respectively. The software provides data visualization and enables the users to train their own models.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords